Augmenting management of obstructive sleep apnea with consumer wearable devices to increase use of positive airway pressure therapy: a pilot randomized trial
- 29 October 2025
- journal article
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 49 (4)
Abstract
Study Objectives: This pilot randomized trial measured the effects of a consumer-grade wearable-augmented program, which provides nightly pulse oximetry data to patients in a weekly report, on positive airway pressure (PAP) use in adults with obstructive sleep apnea (OSA) recruited from an outpatient sleep center. Methods: This single-blind, parallel, two-group waitlist-controlled, single-site randomized trial recruited individuals with OSA with insufficient PAP use from a Department of Veterans Affairs medical center and randomized them to immediate participation in the consumer wearable-augmented self-monitoring program versus waitlist. The primary outcome was the change in modem-measured PAP use (mean hours or minutes per night over a 7-day period) from baseline (T1) to T3 assessment, which was 35 days following randomization (7 days post-intervention for the immediate group and prior to intervention for the waitlist group). Results: We randomized 50 participants (mean age 47.9 years [SD 11.4]; 88% male). The change in PAP use was +1.33 hours (+79.8 minutes) for the immediate group and −0.17 hours (−10.2 minutes) for the waitlist control group, with a between-group difference of 1.50 hours (90 minutes) (p = .0097). The change in the number of days PAP was used for 4 hours or more over a 7-day period was +1.32 days for the immediate and 0.12 days for the waitlist control group, with a between-group difference of 1.20 (p = .0401). Conclusions: This pilot trial demonstrated that the consumer-grade wearable-augmented program is a promising intervention for increasing PAP use. A future full-scale trial that follows participants for a longer period is needed. Statement of Significance This pilot trial tested a novel use of the pulse oximetry feature available on some consumer-grade wearable devices to increase use of positive airway pressure (PAP) devices among adults with obstructive sleep apnea (OSA) and insufficient PAP use. The widespread and growing use of consumer-grade wearable devices offers an opportunity to leverage the features on these devices to tackle a common, problematic issue among individuals with OSA—insufficient use of PAP therapy. The randomized controlled design provides support for future research involving these devices.Keywords
This publication has 15 references indexed in Scilit:
- Prevalence of Obstructive Sleep Apnea Among Veterans and NonveteransAmerican Journal of Health Promotion, 2024
- Melanin bias in pulse oximetry explained by light source spectral bandwidthBritish Journal of Anaesthesia, 2024
- Can we trust the oxygen saturation measured by consumer smartwatches?The Lancet Respiratory Medicine, 2022
- Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnoeaCochrane Database of Systematic Reviews, 2020
- Effect of Telemedicine Education and Telemonitoring on Continuous Positive Airway Pressure Adherence. The Tele-OSA Randomized TrialAmerican Journal of Respiratory and Critical Care Medicine, 2018
- Management of continuous positive airway pressure treatment compliance using telemonitoring in obstructive sleep apnoeaEuropean Respiratory Journal, 2017
- A New mHealth application to support treatment of sleep apnoea patientsJournal of Telemedicine and Telecare, 2016
- An Official American Thoracic Society Statement: Continuous Positive Airway Pressure Adherence Tracking Systems. The Optimal Monitoring Strategies and Outcome Measures in AdultsAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Development of Short Forms From the PROMIS™ Sleep Disturbance and Sleep-Related Impairment Item BanksBehavioral Sleep Medicine, 2012
- A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness ScaleSLEEP, 1991